Results 181 to 190 of about 35,096 (229)

ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death

open access: yesCell Death and Differentiation, 2007
The apoptosis-inducing Fas ligand (FasL) is a type II transmembrane protein that is involved in the downregulation of immune reactions by activation-induced cell death (AICD) as well as in T cell-mediated cytotoxicity.
Thorsten Maretzky   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

The FasLane to ocular pathology—metalloproteinase cleavage of membrane-bound FasL determines FasL function

Journal of Leukocyte Biology, 2021
AbstractFas ligand (FasL) is best known for its ability to induce cell death in a wide range of Fas-expressing targets and to limit inflammation in immunoprivileged sites such as the eye. In addition, the ability of FasL to induce a much more extensive list of outcomes is being increasingly explored and accepted. These outcomes include the induction of
Meredith, Gregory-Ksander   +1 more
openaire   +2 more sources

FasL shedding is reduced by hypothermia in experimental stroke [PDF]

open access: yesJournal of Neurochemistry, 2008
Protection by mild hypothermia has previously been associated with better mitochondrial preservation and suppression of the intrinsic apoptotic pathway.
Jong Youl Kim   +2 more
exaly   +2 more sources

RGD-FasL Induces Apoptosis of Pituitary Adenoma Cells

open access: yesCellular and Molecular Immunology, 2008
This study was to investigate the cytotoxic effects on pituitary adenoma cell lines GH3/MMQ/AtT20 induced by RGD-FasL and the underlying mechanism. Fas/DcR3 mRNAs were detected by RT-PCR and their surface expressions were measured by flow cytometry ...
Lukui Chen, Guohong Zhuang, Wenzhu Li
exaly   +1 more source

FasL Expression and Reverse Signalling

2009
FasL plays a central role in the induction of apoptosis within the immune system. It mediates activation-induced cell death (AICD) of T lymphocytes and contributes to the cytotoxic effector function of T and NK cells. Moreover, FasL is discussed as direct effector molecule for the establishment of immune privilege and tumour survival. Besides its death-
M, Lettau   +3 more
openaire   +2 more sources

FasL and Fas

2007
The membrane receptor Fas is one of the central members of the TNF receptor superfamily, representing the prototype of an apoptosis inducer. Its cognate ligand, FasL, is expressed as a type II transmembrane protein, but also exists as a soluble molecule.
Anja Krippner-Heidenreich   +1 more
openaire   +1 more source

Regulation of FasL expression: A SH3 domain containing protein family involved in the lysosomal association of FasL

Cellular Signalling, 2006
As a death factor of T cells and Natural Killer (NK) cells, Fas Ligand (FasL) is stored in association with secretory lysosomes. Upon stimulation, these cytotoxic granules are transported to the cell membrane where FasL is exposed on the cell surface, shed or secreted.
Jing, Qian   +6 more
openaire   +2 more sources

LKLF and FasL Expression: Correction and Clarification

Science, 1997
In the report “LKLF: A transcriptional regulator of single-positive T cell quiescence and survival” ([26 Sept., p. 1986][1]) ([1][2]), we found increased Fas ligand (FasL) expression on lung Kruppel-like factor (LKLF)–deficient T cells.
C T, Kuo, M L, Veselits, J M, Leiden
openaire   +2 more sources

Differential protein–protein interactions of full length human FasL and FasL fragments generated by proteolysis

Experimental Cell Research, 2014
Fas ligand (FasL) is a death factor of the tumor necrosis factor superfamily. Like other members of this family of type II transmembrane proteins, FasL is subject to ectodomain shedding by a disintegrin and metalloproteinases (ADAMs) liberating soluble FasL and leaving membrane-integral N-terminal fragments (NTFs).
Marcus, Lettau   +4 more
openaire   +2 more sources

The Role of FasL and Fas in Health and Disease

2009
The FS7-associated cell surface antigen (Fas, also named CD95, APO-1 or TNFRSF6) attracted considerable interest in the field of apoptosis research since its discovery in 1989. The groups of Shin Yonehara and Peter Krammer were the first reporting extensive apoptotic cell death induction upon treating cells with Fas-specific monoclonal antibodies.1,2 ...
Martin, Ehrenschwender, Harald, Wajant
openaire   +2 more sources

Home - About - Disclaimer - Privacy